Skip to content

Clinical trials

Narcolepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Country / region: United States Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20044
20051
20061
20071
20093
20102
20111
20124
20143
20153
20161
20171
20181
20196
20205
20218
20221
20235
20246
20255
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting16
Terminated3
Withdrawn1
No longer available1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals15
Axsome Therapeutics, Inc.5
Cephalon5
Alkermes, Inc.4
Harmony Biosciences Management, Inc.4
Avadel3
Brigham and Women's Hospital3
Merck Sharp & Dohme LLC3
Northwestern University3
Centessa Pharmaceuticals (UK) Limited2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy75
Disorders of Excessive Somnolence29
Cataplexy13
Sleep Apnea, Obstructive12
Idiopathic Hypersomnia10
Sleep Wake Disorders6
Fatigue5
Sleep Disorders, Circadian Rhythm5
Sleep Initiation and Maintenance Disorders5
Sleepiness4

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.